Projects

Prevalence, Risk factors, COnsequences and opporTunities for prevention of falls in Elderly with select Chronic condiTions (PROTECT 2): A Mixed Methods Study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - Ongoing

Project Lead

Dr. Denis Xavier

Authors

PI- Dr. Denis Xavier, Co-I: Dr. Atiya Faruqui, Dr. Arvind Kasturi, Dr. Jonita Furtado, Dr. Pretesh R

Project Status

ongoing